title: Does rosuvastatin offer therapeutic potential in autoimmune thyroiditis in nonobese diabetic mice?
authors.forename: Kouki
authors.initials: K
authors.lastname: Mori
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Nakagawa
authors.forename: Saeko
authors.initials: S
authors.lastname: Hoshikawa
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Ozaki
authors.forename: Sadayoshi
authors.initials: S
authors.lastname: Ito
authors.forename: Katsumi
authors.initials: K
authors.lastname: Yoshida
mesh_terms: D000818:Animals; D000906:Antibodies / Q000097:blood; D005464:Fluorobenzenes / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D016688:Mice, Inbred NOD; D011743:Pyrimidines / Q000494:pharmacology* / Q000627:therapeutic use; D000068718:Rosuvastatin Calcium; D012974:Sodium Iodide / Q000494:pharmacology; D013154:Spleen / Q000166:cytology / Q000187:drug effects; D013449:Sulfonamides / Q000494:pharmacology* / Q000627:therapeutic use; D013954:Thyroglobulin / Q000494:pharmacology; D013967:Thyroiditis, Autoimmune / Q000139:chemically induced / Q000188:drug therapy
chemical_list: D000906:Antibodies; D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D013954:Thyroglobulin; D012974:Sodium Iodide